Ferric Carboxymatose in Non-Hemodialysis CKD Patients: A Longitudinal Cohort Study

No information is available on the efficacy of ferric carboxymaltose (FCM) in real-world CKD patients outside the hemodialysis setting. We prospectively followed 59 non-hemodialysis CKD patients with iron deficient anemia (IDA: hemoglobin <12.0/<13.5 g/dL in women/men and TSAT < 20% and/or...

Descripción completa

Detalles Bibliográficos
Autores principales: Minutolo, Roberto, Berto, Patrizia, Liberti, Maria Elena, Peruzzu, Nicola, Borrelli, Silvio, Netti, Antonella, Garofalo, Carlo, Conte, Giuseppe, De Nicola, Luca, Del Vecchio, Lucia, Locatelli, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005153/
https://www.ncbi.nlm.nih.gov/pubmed/33806864
http://dx.doi.org/10.3390/jcm10061322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005153/
https://www.ncbi.nlm.nih.gov/pubmed/33806864
http://dx.doi.org/10.3390/jcm10061322

Ejemplares similares